The relative importance of dopamine and norepinephrine in mediating locomotor activity.
D018674:Adrenergic Antagonists; D000662:Amphetamines / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001696:Biomechanical Phenomena; D001923:Brain Chemistry; D002395:Catecholamines / Q000378:metabolism; D003000:Clonidine / Q000494:pharmacology; D003342:Corpus Striatum / Q000502:physiology; D004298:Dopamine / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology / Q000502:physiology*; D015103:Droxidopa / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D007980:Levodopa / Q000494:pharmacology; D008032:Limbic System / Q000502:physiology; D008124:Locomotion / Q000187:drug effects; D009434:Neural Pathways / Q000502:physiology; D018377:Neurotransmitter Agents / Q000037:antagonists & inhibitors; D009638:Norepinephrine / Q000096:biosynthesis / Q000494:pharmacology / Q000502:physiology*; D009714:Nucleus Accumbens / Q000502:physiology; D011433:Propranolol / Q000494:pharmacology; D011954:Receptors, Dopamine / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000502:physiology; D012702:Serotonin Antagonists / Q000494:pharmacology; D013378:Substantia Nigra / Q000502:physiology; D013764:Tetrahydronaphthalenes / Q000494:pharmacology
D018674:Adrenergic Antagonists; D000662:Amphetamines; D002395:Catecholamines; D018377:Neurotransmitter Agents; D011954:Receptors, Dopamine; D012702:Serotonin Antagonists; D013764:Tetrahydronaphthalenes; D012701:Serotonin; D007980:Levodopa; C011639:ADTN; D012110:Reserpine; D011433:Propranolol; D015103:Droxidopa; D007545:Isoproterenol; D003000:Clonidine; D001058:Apomorphine; D004298:Dopamine; D009638:Norepinephrine